# ALX Oncology Holdings Inc. (ALXO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALXO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -35.90M | $ -34.77M | $ 9.71M | $ 136.19M |
| 2025 | $ 0 | $ -104.13M | $ -86.37M | $ 5.22M | $ 25.98M |
| 2024 | $ 0 | $ -141.74M | $ -128.61M | $ 9.90M | $ 113.62M |
| 2023 | $ 0 | $ -173.87M | $ -142.33M | $ 17.20M | $ 189.71M |
| 2022 | $ 0 | $ -137.94M | $ -101.27M | $ 10.43M | $ 263.46M |
| 2021 | $ 0 | $ -99.21M | $ -86.80M | $ 742.0K | $ 363.05M |
| 2020 | $ 1.51M | $ -58.27M | $ -48.82M | $ 0 | $ 429.85M |
| 2019 | $ 6.19M | $ -24.84M | $ -18.85M | $ 5.42M | $ -276.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.18 |
| Current Ratio | 9.71 |

## Other views

- [Metrics](https://sponda.capital/en/ALXO.md)
- [Charts](https://sponda.capital/en/ALXO/charts.md)
- [Compare](https://sponda.capital/en/ALXO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.